Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Additional Information (Detail)

v3.19.2
Commitments and Contingencies - Additional Information (Detail)
1 Months Ended 6 Months Ended
Nov. 30, 2016
USD ($)
ft²
Nov. 30, 2017
USD ($)
Oct. 31, 2017
Nov. 30, 2016
USD ($)
ft²
Jun. 30, 2019
USD ($)
Milestone
Alachua Facility [Member]          
Commitment And Contingencies [Line Items]          
Period of lease         5 years
Lease commencement date         Dec. 31, 2014
Amendment Alachua Facility [Member]          
Commitment And Contingencies [Line Items]          
Period of lease         5 years
Lease commencement date         Dec. 31, 2019
Tampa Facility [Member]          
Commitment And Contingencies [Line Items]          
Period of lease 36 months     36 months  
Lease commencement date       Mar. 01, 2017  
Area of Office Space Leased | ft² 2,207     2,207  
Expiration period Feb. 29, 2020        
Minimum [Member] | Alachua Facility [Member]          
Commitment And Contingencies [Line Items]          
Monthly lease payments         $ 9,641
Minimum [Member] | Amendment Alachua Facility [Member]          
Commitment And Contingencies [Line Items]          
Monthly lease payments         12,870
Minimum [Member] | Tampa Facility [Member]          
Commitment And Contingencies [Line Items]          
Monthly lease payments $ 4,138     $ 4,138  
Maximum [Member] | Alachua Facility [Member]          
Commitment And Contingencies [Line Items]          
Monthly lease payments         10,851
Maximum [Member] | Amendment Alachua Facility [Member]          
Commitment And Contingencies [Line Items]          
Monthly lease payments         $ 13,338
Maximum [Member] | Tampa Facility [Member]          
Commitment And Contingencies [Line Items]          
Monthly lease payments $ 4,392     $ 4,392  
Lantibiotic ECC [Member]          
Commitment And Contingencies [Line Items]          
Company's obligation to pay from all revenue received from sublicenses   25.00%     25.00%
Royalty rate based on percentage of net sales   10.00%      
Company's obligation to pay from percentage of selling price of product         10.00%
Number of milestones achieved | Milestone         0
Lantibiotic ECC [Member] | Minimum [Member]          
Commitment And Contingencies [Line Items]          
Amount required to be expended for advancement of lantibiotic program   $ 1,200,000      
Lantibiotic ECC [Member] | Scenario, Previously Reported [Member]          
Commitment And Contingencies [Line Items]          
Company's obligation to pay from all revenue received from sublicenses     50.00%    
Royalty rate based on percentage of product profit     25.00%    
Lantibiotic ECC [Member] | New Drug Application [Member]          
Commitment And Contingencies [Line Items]          
Milestone payment under licensing agreement   $ 25,000,000     $ 25,000,000
Milestone measurement period   6 months     6 months
Lantibiotic ECC [Member] | New Indication Milestone Event [Member]          
Commitment And Contingencies [Line Items]          
Milestone payment under licensing agreement         $ 5,000,000
Milestone measurement period         6 months
Lantibiotic ECC [Member] | New Product Milestone Event [Member]          
Commitment And Contingencies [Line Items]          
Milestone payment under licensing agreement         $ 5,000,000
Milestone measurement period         6 months
Oral Mucositis ECC [Member]          
Commitment And Contingencies [Line Items]          
Company's obligation to pay from all revenue received from sublicenses   25.00%     25.00%
Company's obligation to pay from percentage of selling price of product         12.00%
Number of milestones achieved | Milestone         0
Oral Mucositis ECC [Member] | Maximum [Member]          
Commitment And Contingencies [Line Items]          
Maturity of interest bearing promissory note         12 months
Oral Mucositis ECC [Member] | Scenario, Previously Reported [Member]          
Commitment And Contingencies [Line Items]          
Company's obligation to pay from all revenue received from sublicenses     50.00%    
Oral Mucositis ECC [Member] | New Indication Milestone Event [Member]          
Commitment And Contingencies [Line Items]          
Milestone payment under licensing agreement         $ 5,000,000
Milestone measurement period         6 months
Oral Mucositis ECC [Member] | New Product Milestone Event [Member]          
Commitment And Contingencies [Line Items]          
Milestone payment under licensing agreement         $ 5,000,000
Milestone measurement period         6 months
Oral Mucositis ECC [Member] | New Product Application [Member]          
Commitment And Contingencies [Line Items]          
Milestone payment under licensing agreement   $ 27,500,000     $ 27,500,000
Milestone measurement period   6 months     6 months